
Thomas Leung
@realthomasleung
Dermatologist scientist, regenerative medicine, loves my family, sports addict
ID: 281344696
http://thomasleunglab.org 13-04-2011 03:27:19
328 Tweet
187 Followers
168 Following

I love to joke around and make fun of old people like Thomas Leung, but I won't today since his lab has shown that old mice are actually better at something. cell.com/cell-reports/f…

Mailyn Nishiguchi - Leung lab Thomas Leung in Cell Reports "Aging Suppresses Skin-Derived Circulating SDF1 to Promote Full-Thickness Tissue Regeneration" cell.com/cell-reports/f…

Countering current dogma: Aging Suppresses Skin-Derived Circulating SDF1 to Promote Full-Thickness Tissue Regeneration Penn Singapore Management University Cell Reports Thomas Leung ow.ly/EML130m3tfk



Top Stories 2018 #8: Countering current dogma: aging suppresses skin-derived circulating SDF1 to promote full-thickness tissue regeneration Penn Singapore Management University Cell Reports Thomas Leung bit.ly/2GzaKE3

Looking forward to NYC- staying at the Hilton Midtown. For friends traveling soon: flip.to/r/1pkw NY Hilton Midtown

Two years ago, I fell in love with this amazing (best) specialty (dermatology), found incredible mentors along the way (Thomas Leung, Misha Rosenbach, MD,Albert Yan et al), & worked on super duper cool research in wound healing. Here’s what we found: 😍🥳😊 immunology.sciencemag.org/content/5/50/e…

I don't tweet as much as I should. Our latest work on scarless skin regeneration in Science Immunology. Congratulations to Jenny Wei, MD Misha Rosenbach, MD immunology.sciencemag.org/content/5/50/e…





Congratulations to Thomas Leung (Penn Medicine Dermatology) on his election to ASCI!🎉 Learn more about Dr. Leung & his work here➡️ thomasleunglab.org #PSOMatASCI


Granulomas guide researchers to an FDA-approved drug for sarcoidosis. Sati et al. identify type 1 innate lymphoid cells as a biomarker for sarcoidosis and find plerixafor-treated mice develop fewer lung granulomas. Thomas Leung Penn Medicine

Granulomas guide researchers to an FDA-approved drug for sarcoidosis: jci.org/articles/view/… ASCI member Thomas Leung Penn Medicine & team identify type 1 innate lymphoid cells as a biomarker for sarcoidosis and find plerixafor-treated mice develop fewer lung granulomas.



elifesciences.org/articles/33511 Chris Natale great summary of your outstanding work!


Our lab members combat racism after hours, go @livinyoung1105 !! Via The Daily Pennsylvanian thedp.com/article/2018/0…